🔥🐔 BizChicken 🐔🔥

Companies Similar to ANI Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Athira Pharma, Inc.

Athira Pharma, Inc. logo
Market Cap: Lowest
Employees: Low

ATH-1017

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.

Tags: Alzheimer's disease, Parkinson's disease, biopharmaceutical, clinical trials, neurodegeneration

Symbol: ATHA

Recent Price: $0.55

Industry: Biotechnology

CEO: Dr. Mark J. Litton M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 18706 North Creek Parkway, Bothell, WA 98011

Phone: 425 620 8501

Last updated: 2024-12-31

Anixa Biosciences, Inc.

Anixa Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines

Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.

Tags: CAR-T therapy, COVID-19, anti-viral drugs, biotechnology, infectious diseases, oncology, vaccine development

Symbol: ANIX

Recent Price: $2.50

Industry: Biotechnology

CEO: Dr. Amit Kumar Ph.D.

Sector: Healthcare

Employees: 4

Address: 3150 Almaden Expressway, San Jose, CA 95118

Phone: 408 708 9808

Last updated: 2024-12-31

AnaptysBio, Inc.

AnaptysBio, Inc. logo
Market Cap: Medium
Employees: Low

Imsidolimab, Rosnilimab, ANB032

Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.

Tags: antibody development, biotechnology, immuno-oncology, inflammation, therapeutics

Symbol: ANAB

Recent Price: $13.22

Industry: Biotechnology

CEO: Mr. Daniel R. Faga

Sector: Healthcare

Employees: 117

Address: 10770 Wateridge Circle, San Diego, CA 92121-5801

Phone: 858 362 6295

Last updated: 2024-12-31

Ikena Oncology, Inc.

Ikena Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

IK-930

Ikena Oncology is a targeted oncology company developing medicines tailored to biomarker-defined patient groups, with a focus on unmet needs in cancer treatment.

Tags: biomarkers, biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: IKNA

Recent Price: $1.60

Industry: Biotechnology

CEO: Dr. Mark Manfredi Ph.D.

Sector: Healthcare

Employees: 18

Address: 645 Summer Street, Boston, MA 02210

Phone: 857 273 8343

Last updated: 2024-12-31

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Medium

Branded and generic prescription pharmaceuticals

ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals, focusing on controlled substances, oncology products, hormones, steroids, injectables, and other formulations in the United States and Canada.

Tags: biopharmaceutical, controlled substances, hormones, injectables, oncology, prescription drugs, steroids

Symbol: ANIP

Recent Price: $54.87

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Nikhil Lalwani

Sector: Healthcare

Employees: 642

Address: 210 Main Street West, Baudette, MN 56623

Phone: 218 634 3500

Last updated: 2024-12-31

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Highest

Emverm, Rytary, Unithroid

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across various dosage forms and therapeutic areas, operating through Generics, Specialty, and Av KARE segments.

Tags: Generics, Healthcare, Pharmaceuticals, Specialty, Therapeutics

Symbol: AMRX

Recent Price: $7.83

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Chirag K. Patel

Sector: Healthcare

Employees: 7850

Address: 400 Crossing Boulevard, Bridgewater, NJ 08807

Phone: 908 947 3120

Leadership

  • Chirag Patel, President and Co-Chief Executive Officer
  • Chintu Patel, Co-Chief Executive Officer
  • Tasos Konidaris, Executive Vice President, Chief Financial Officer
  • Nikita Shah, Executive Vice President, Chief Human Resources Officer
  • Jason B. Daly, Esq., Senior Vice President, Chief Legal Officer & Corporate Secretary
  • Gregory Sgammato, Senior Vice President, Corporate Development
  • Andrew S. Boyer, Executive Vice President, Chief Commercial Officer – Generics
  • Joe Renda, Senior Vice President, Chief Commercial Officer - Specialty
  • Shyamakant Giri, President, India Business & Emerging Markets
  • Sanjay Kumar Jain, PhD, Chief Quality Officer
  • Srinivas Kone, PhD, Senior Vice President, Chief Scientific Officer – Generics
  • Richard D’Souza, PhD, Senior Vice President, Specialty R&D
  • Maryll W. Toufanian, Senior Vice President, Regulatory Strategy and Government Affairs
  • Pranav Mehta, Senior Vice President, Strategic Sourcing & Supply Management
  • Sandeep R. Raktate, President, Operations – India & Ireland

Last updated: 2024-12-31

Eli Lilly and Company

Eli Lilly and Company logo
Market Cap: Highest
Employees: Highest

Pharmaceuticals

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.

Tags: Biotechnology, Cancer Treatment, Diabetes, Pharmaceuticals

Symbol: LLY

Recent Price: $773.84

Industry: Drug Manufacturers - General

CEO: Mr. David A. Ricks

Sector: Healthcare

Employees: 43000

Address: Lilly Corporate Center, Indianapolis, IN 46285

Phone: 317 276 2000

Last updated: 2024-12-31

Pfizer Inc.

Pfizer Inc. logo
Market Cap: Highest
Employees: Highest

biopharmaceutical products

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.

Tags: COVID-19, biopharmaceuticals, biosimilars, medicines, therapeutic areas, vaccines

Symbol: PFE

Recent Price: $26.42

Industry: Drug Manufacturers - General

CEO: Dr. Albert Bourla D.V.M., Ph.D.

Sector: Healthcare

Employees: 88000

Address: 235 East 42nd Street, New York, NY 10017

Phone: 212 733 2323

Last updated: 2024-12-31

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANEB-001

Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.

Tags: ANEB-001, biotechnology, cannabinoid intoxication, clinical-stage, substance addiction

Symbol: ANEB

Recent Price: $1.64

Industry: Biotechnology

CEO: Mr. Richard Anthony Cunningham

Sector: Healthcare

Employees: 2

Address: 1415 Ranch Road 620 South, Lakeway, TX 78734

Phone: 512 598 0931

Last updated: 2024-12-31

Annexon, Inc.

Annexon, Inc. logo
Market Cap: Medium
Employees: Low

ANX005

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. It develops several investigational monoclonal antibodies targeting distinct disease processes.

Tags: autoimmune, biopharmaceutical, clinical trials, neurodegeneration, therapeutics

Symbol: ANNX

Recent Price: $5.13

Industry: Biotechnology

CEO: Mr. Douglas Love Esq., J.D.

Sector: Healthcare

Employees: 71

Address: 1400 Sierra Point Parkway, Brisbane, CA 94005

Phone: 650 822 5500

Last updated: 2024-12-31

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logo
Market Cap: Medium
Employees: Lowest

ANAVEX 2-73

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.

Tags: Alzheimer's, CNS diseases, Parkinson's, Rett syndrome, biopharmaceutical, clinical trials, neurodegenerative diseases

Symbol: AVXL

Recent Price: $11.04

Industry: Biotechnology

CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Sector: Healthcare

Employees: 40

Address: 51 West 52nd Street, New York, NY 10019

Phone: 844 689 3939

Last updated: 2024-12-31

Moleculin Biotech, Inc.

Moleculin Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Annamycin

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing drug candidates for highly resistant tumors and viruses. Its lead product, Annamycin, is in Phase 1/2 studies, and it also works on other candidates targeting brain tumors, pancreatic cancer, and COVID-19.

Tags: Biotech, Cancer treatment, Clinical-stage, Drug development, Pharmaceutical, Phase 1/2 studies

Symbol: MBRX

Recent Price: $1.79

Industry: Biotechnology

CEO: Mr. Walter V. Klemp

Sector: Healthcare

Employees: 18

Address: 5300 Memorial Drive, Houston, TX 77007

Phone: 713 300 5160

Last updated: 2024-12-31

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANA001

A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.

Tags: biotechnology, cardiometabolic diseases, clinical trials, infectious diseases, neurodegenerative diseases

Symbol: NRBO

Recent Price: $2.36

Industry: Biotechnology

CEO: Mr. Hyung-Heon Kim

Sector: Healthcare

Employees: 8

Address: 200 Berkeley Street, Boston, MA 02116

Phone: 857 702 9600

Last updated: 2024-12-31

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. logo
Market Cap: Lowest
Employees: Lowest

INTASYL therapeutic platform

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.

Tags: ACT, BRD4, Biotechnology, Cancer, Immuno-Oncology, PD-1, TIGIT, Therapeutics

Symbol: PHIO

Recent Price: $1.90

Industry: Biotechnology

CEO: Mr. Robert J. Bitterman

Sector: Healthcare

Employees: 8

Address: 257 Simarano Drive, Marlborough, MA 01752

Phone: 508 767 3861

Last updated: 2024-12-31

Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Anticalin-based drugs

Pieris Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on discovering and developing anticalin-based drugs for respiratory diseases, idiopathic pulmonary fibrosis, and cancer.

Tags: anticalin, biopharmaceutical, clinical trials, drug development, immuno-oncology, respiratory diseases

Symbol: PIRS

Recent Price: $13.60

Industry: Biotechnology

CEO: Mr. Stephen S. Yoder J.D.

Sector: Healthcare

Employees: 46

Address: 255 State Street, Boston, MA 02109

Phone: 857 246 8998

Last updated: 2024-12-31

Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. logo
Market Cap: Low
Employees: Low

Rani Pill

Rani Therapeutics Holdings, Inc. is a clinical stage biotherapeutics company focused on developing orally administered biologics with its Rani Pill platform, aimed at replacing subcutaneous or IV injections. The company has multiple products in various stages of development targeting conditions like neuroendocrine tumors, psoriatic arthritis, osteoporosis, growth hormone deficiency, hypoparathyroidism, and type 2 diabetes.

Tags: Rani Pill, biologics, biotherapeutics, clinical trials, healthcare, pharmaceuticals

Symbol: RANI

Recent Price: $1.48

Industry: Biotechnology

CEO: Mr. Talat Imran

Sector: Healthcare

Employees: 140

Address: 2051 Ringwood Avenue, San Jose, CA 95131

Phone: 408 457 3700

Leadership

  • Talat Imran, Chief Executive Officer
  • Mir Imran, Founder and Executive Chairman
  • Mir Hashim, Chief Scientific Officer
  • Svai Sanford, Chief Financial Officer
  • Eric Groen, General Counsel
  • Kate McKinley, Chief Business Officer
  • Jacques Van Dam, Vice President, Medical Affairs
  • Alireza Javadi, VP of Technical Operations
  • Betsy Gutierrez, Vice President, Quality Assurance
  • Bella Vazquez, Vice President, Human Resources
  • Kyle Horlen, VP of Nonclinical Development & Safety Assessment
  • Arvinder Dhalla, Vice President, Clinical Development
  • Andrew Farquharson, Managing Director, VHM and InCube Ventures
  • Maulik Nanavaty, CEO of Anumana
  • Jean-Luc Butel, Director at Takeda, Novo Holdings, and SG Innovate
  • Laureen DeBuono, Managing Partner, FLG Partners
  • Dennis Ausiello, Director of CATCH & Former Chief of Medicine, Mass General
  • Lisa Rometty, President, CVS Kidney Care

Last updated: 2024-12-31

Talphera, Inc.

Talphera, Inc. logo
Market Cap: Lowest
Employees: Lowest

Niyad

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company develops products like Niyad, LTX-608, Fedsyra, and PFS-02, with applications in anticoagulant, anti-inflammatory, and antiviral treatments.

Tags: anti-inflammatory, anticoagulants, antiviral, healthcare, pharmaceuticals

Symbol: TLPH

Recent Price: $0.54

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Vincent J. Angotti

Sector: Healthcare

Employees: 15

Address: 1850 Gateway Drive, San Mateo, CA 94404

Phone: 650 216 3500

Last updated: 2024-12-31

Viatris Inc.

Viatris Inc. logo
Market Cap: Highest
Employees: Highest

Prescription Brand Drugs, Generic Drugs, Complex Generic Drugs, Biosimilars, APIs

Viatris Inc. operates as a healthcare company worldwide, offering prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and APIs across various therapeutic areas, along with support services to help patients manage health.

Tags: APIs, biosimilars, generic drugs, healthcare, pharmaceuticals, therapeutic areas

Symbol: VTRS

Recent Price: $12.38

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Scott Andrew Smith

Sector: Healthcare

Employees: 33000

Address: 1000 Mylan Boulevard, Canonsburg, PA 15317

Phone: 724 514 1800

Last updated: 2024-12-31

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

N/A

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.

Tags: SARS-Co V-2, biotechnology, hepatitis B virus, liver diseases, pharmaceuticals, respiratory syncytial virus, small molecule drugs, viral infections

Symbol: ENTA

Recent Price: $5.85

Industry: Biotechnology

CEO: Dr. Jay R. Luly Ph.D.

Sector: Healthcare

Employees: 145

Address: 500 Arsenal Street, Watertown, MA 02472

Phone: 617 607 0800

Leadership

  • Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
  • Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
  • Matthew P. Kowalsky, J.D., Chief Legal Officer
  • Brendan Luu, Chief Business Officer
  • Paul J. Mellett, Chief Financial and Administrative Officer
  • Yat Sun Or, Ph.D., Chief Scientific Officer
  • Scott T. Rottinghaus, M.D., Chief Medical Officer
  • Bruce L.A. Carter, Ph.D., Chairman of the Board
  • Mark G. Foletta, Board Member
  • Yujiro S. Hata, Board Member
  • Kristine Peterson, Board Member
  • Lesley Russell, MBChB, MRCPb, Board Member
  • Terry Vance, Board Member

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08